No information
No information is present at this moment.
No information is present at this moment.
| Hypokalaemia |
|---|
|
| Maintenance requirement for potassium in TPN |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Hyperkalaemia, gastrointestinal disorders (OR), intestinal ulcers (OR)
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Intravenous: Do not administer undiluted as a bolus. Be aware of the potential for arrhythmia when infused too fast: the maximum concentration for a peripheral line: 0.08 mmol/ml, i.e. add a maximum of 40 mmol to 500 ml.
Watch out for renal insufficiency and potassium sparing diuretics.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.